Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BDR-531
- Development stage
- Preclinical
- Lead developer
- BioDrone Therapeutics
- Modality
- Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
BDR-531 is a preclinical **MSC-derived cell-derived vesicle** therapeutic program from **BioDrone Therapeutics** for **inflammatory diseases**. It is part of the company's CDV platform and appears to use mesenchymal stem cell-derived extracellular vesicles as a **cell therapy / exosome-based therapy** approach intended to deliver the intrinsic immunomodulatory and anti-inflammatory activity of MSC-derived vesicles, and potentially therapeutic cargo, to inflamed tissues. Publicly available pipeline information identifies the program, modality, disease area, and preclinical status, but does not disclose a specific molecular target, formulation details, route of administration, or disease-specific indication beyond inflammatory conditions.
- Other names
- BioDrone Therapeutics BDR-531MSC-derived cell-derived vesicle therapy
Beyond the preview
Go deeper on BDR-531.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BDR-531.